Tegoprazan: all 63 studies that test it
Page 1 of 1. Open to participants first (15), then studies with results posted, then the rest; newest registration first within each.
- Tegoprazan-Aspirin Drug Interaction in Healthy Adult Male VolunteersNot yet recruitingNCT07853248Phase 1
- A Study to Evaluate Tegoprazan as a Diagnostic Tool for GERDNot yet recruitingNCT07826455Phase 4
- Tegoprazan Versus Lansoprazole for Endoscopic Ulcer Healing in Bleeding Peptic UlcersRecruitingNCT07708545Phase 2
- Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke)RecruitingNCT07687706Phase 3
- A Study to Evaluate the Pharmacokinetics and Food-effect of IN-M00002 Tablet in Healthy Adult VolunteersNot yet recruitingNCT07277712Phase 1
- Head-to-head Study of Tegoprazan 50 mg BID Plus Amoxicillin 1 g TID vs. Vonoprazan 20 mg BID Plus Amoxicillin 1 g TID for H. Pylori EradicationRecruitingNCT07242456Phase 2/3
- Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Disease With the Administration of Tegoprazan or PantoprazoleRecruitingNCT06991348Phase 4
- Tegoprazan And Lansoprazole Effectiveness in Bleeding Peptic Ulcer TreatmentRecruitingNCT06894992Not applicable
- Effect of Tegoprazan for Elective Surgery Patients Under General AnesthesiaEnrolling by invitationNCT06743243Phase 4
- PK, PD and Safety of Tegoprazan 12.5 mg After Oral Administration in Healthy SubjectsEnrolling by invitationNCT06332638Phase 1
- Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Tegoprazan vs EsomeprazoleNot yet recruitingNCT06318104Phase 4
- Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy SubjectsNot yet recruitingNCT06164834Phase 1
- Exploratory Study to Standard Triple Therapy With Tegoprazan(by Dose) in H. Pylori Positive PatientsRecruitingNCT05933031Phase 2
- Comparison of Two Dual Therapies in the First-line Treatment of Helicobacter Pylori Infection （SHARE2301）RecruitingNCT05870683Not applicable
- A Study to Evaluate the Efficacy and Safety of Tegoprazan in GERD Patients With Nighttime HeartburnRecruitingNCT05701540Phase 4
- Efficacy and Safety of Tegoprazan and Minocycline Dual Therapy for Helicobacter Pylori Initial TreatmentActive, not recruitingNCT06523764Phase 4
- Drug Interaction Study Between Tegoprazan, Bismuth, Amoxicillin and ClarithromycinCompletedNCT05915871Phase 1
- A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux DiseaseCompletedNCT05890001Phase 3
- Mass Balance and Biotransformation Study of [14C]LXI-15028 in HumansCompletedNCT05883306Phase 1
- The Efficacy of Potassium-competitive Acid Blocker in Patients With Laryngopharyngeal Reflux DiseaseCompletedNCT05871398Phase 3
- Effect of H. Pylori Eradication on Alleviating Symptoms in Functional Dyspepsia PatientsStatus unknownNCT05786807Phase 4
- PK and PD Interaction Between Tegoprazan and NOACs After Multiple Oral Dosing in Healthy VolunteersCompletedNCT05723510Phase 1
- Tegoprazan-Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for H. Pylori Infection (TATH-1)CompletedNCT05647278Phase 4
- A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Non-Erosive Reflux DiseaseCompletedNCT05587322Phase 3
- A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive EsophagitisCompletedNCT05587309Phase 3
- Efficacy and Safety of Tegoprazan Versus Esomeprazole-containing Bismuth Quadruple Therapy for Eradication of Helicobacter PyloriCompletedNCT05577468Phase 3
- A Study to Evaluate Effect of IN-A001 on Pharmacokinetics of Tacrolimus in Healthy VolunteersStatus unknownNCT05353010Phase 1
- Study to Confirm the Safety and Efficacy of Tegoprazan in Patients With Healed Erosive Reflux DiseaseCompletedNCT05267743Phase 4
- Efficacy and Safety of LXI-15028 Comparing With Lansoprazole in the Treatment of Duodenal UlcerCompletedNCT05010954Phase 3
- Study to Evaluate the Safety, Efficacy of Tegoprazan for the Prevention of PUD in Patients on Treatment With NSAIDsCompletedNCT04840550Phase 3
- Efficacy of Tegoprazan Based Bismuth Quadruple Therapy for Helicobacter Pylori InfectionStatus unknownNCT04674774Not applicable
- Pharmacokinetic Interaction Between Tegoprazan and NSAIDs After Multiple Oral Dosing in Healthy Male VolunteersCompletedNCT04639804Phase 1
- Study to Evaluate the Influence of Tegoprazan on the Pharmacokinetics of Proguanil in Healthy VolunteersCompletedNCT04568772Phase 1
- A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy ControlsStatus unknownNCT04494269Phase 1
- Change of Gut Microbiome and Symptom After H.Pylori Eradication Therapy in Patients With Functional DyspepsiaStatus unknownNCT04449185Phase 4
- Study to Evaluate the Efficacy and Safety of Tegoprazan in ERD Patients With Nighttime Heartburn and Sleep DisturbanceCompletedNCT04309916Phase 4
- Study to Evaluate the Pharmacodynamics After Single Oral Dosing of Tegoprazan, EAPA115 and RAPA115 in Healthy VolunteersCompletedNCT04231136Phase 1
- Effect of Tegoprazan or RAPA114 on Pharmacokinetic of Atorvastatin in Healthy Adult VolunteersCompletedNCT04221321Phase 1
- Effect of Tegoprazan or RAPA113 on Pharmacodynamics/Pharmacokinetics of Clopidogrel in Healthy Male VolunteersCompletedNCT04171687Phase 1
- Triple Therapy With Tegoprazan in H. Pylori Positive Patients_PILOTCompletedNCT04128917Phase 3
- Evaluate the PK of Multiple Oral Doses of Tegoprazan, Metronidazole, Tetracycline and Bismuth in Healthy VolunteersCompletedNCT04066257Phase 1
- Study to Confirm the Safety and Efficacy of Tegoprazan in Patients With Healed Erosive EsophagitisCompletedNCT04022096Phase 3
- Food-Effect on PK and PD of Single Oral Dose of Tegoprazan in Healthy Male SubjectsCompletedNCT03863938Phase 1
- Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Male ParticipantsCompletedNCT03814642Phase 1
- Efficacy and Safety of LXI-15028 Comparing With Esomeprazole in the Treatment of Erosive EsophagitisCompletedNCT03615677Phase 3
- A Multi-center, Randomized, Double-blind, Parallel-group, Placebo Controlled Phase III Study to Evaluate the Efficacy and Safety of LXI-15028 in Non-erosive Reflux Disease in Chinese Patients for 4 WeeksCompletedNCT03591653Phase 3
- A Phase 1 Study of Tegoprazan on Healthy Male VolunteersStatus unknownNCT03530228Phase 1
- Triple Therapy With Tegoprazan in H. Pylori Positive PatientsCompletedNCT03498456Phase 3
- A Phase I Study of LuoXin Innovate (LXI-15028) in Healthy Chinese Subjects to Evaluate the Pharmacokinetics, Safety and Tolerability.CompletedNCT03458650Phase 1
- A Study to Evaluate Safety, Tolerability, and PD of Tegoprazan on Healthy Male VolunteersCompletedNCT03378284Phase 1
- A Phase 3 Study to Evaluate the Efficacy and Safety of Triple Therapy With CJ-12420 in H. Pylori Positive PatientsCompletedNCT03317223Phase 3
- Pharmacodynamic Properties of CJ-12420 on Evening DosingCompletedNCT03043521Phase 1
- To Investigate PK and PD of CJ-12420, Clarithromycin, Amoxicillin After Multiple Dose AdministrationCompletedNCT03011996Phase 1
- To Investigate Pharmacokinetics and Pharmacodynamics of CJ-12420 After Single and Multiple Dose AdministrationCompletedNCT03009760Phase 1
- Study to Confirm the Safety and Efficacy of CJ-12420 in Patients With Erosive EsophagitisCompletedNCT03006874Phase 3
- A Study to Compare the Pharmacokinetic Characteristics of CJ-12420CompletedNCT02995239Phase 1
- Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Gastric UlcerCompletedNCT02761512Phase 3
- Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Non Erosive Reflux DiseaseCompletedNCT02556021Phase 3
- Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive EsophagitisCompletedNCT02456935Phase 3
- Drug-Drug Interaction Study Between CJ-12420 and Clarithromycin in Healthy Male SubjectsCompletedNCT02052336Phase 1
- Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive EsophagitisCompletedNCT02028663Phase 2
- Food-Effect on PK and PD of Single Oral Dose of CJ-12420 in Healthy Male SubjectsCompletedNCT01830309Phase 1
- Safety, Tolerability, PK, PD of Escalating Single and Multiple Oral Doses of CJ-12420 in Healthy Male SubjectsCompletedNCT01473173Phase 1